| Followers | 90 |
| Posts | 20290 |
| Boards Moderated | 3 |
| Alias Born | 11/05/2005 |
Sunday, April 01, 2007 11:48:34 PM
I see IDIX as way undervalued and as Dew has pointed out, Novartis owns a ton at $20+ and they are not in the biz of
losing capital to an investment in a company that they are
partners with and have a very sizable stake and interest in.
As a former analyst, and running some variables, projections, and the market in HBV, the pps of Idenix appears well undervalued and though market sentiment has a large part
in the pps, the science should speak loud enough once fully presented to warrant a very nice pps appreciation from these depressed levels imho. HBV is a woldwide major problem and these drugs are very needed and very soon.....take care and thanx for your well thought out post....
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
